Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine (SHR8554) in Acute Postoperative Pain After Orthopedic Surgery
NCT04794738Phase 3Unknown
- Sponsor
- Hengrui
- Start
- Apr 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tegileridine in acute postoperative pain (4 arms), sponsored by Hengrui. Primary endpoint: Sum of Pain Intensity Differences in Pain Score Over 48 Hours in the rest state. Status: unknown.
02
Drugs
tegileridine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT04794738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04794738.